Company Filing History:
Years Active: 2020-2022
Title: Mark Kagan: Innovator in Pharmaceutical Chemistry
Introduction
Mark Kagan is a notable inventor based in East Hanover, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NEP inhibitors. With a total of 2 patents, Kagan's work has the potential to impact therapeutic applications significantly.
Latest Patents
Kagan's latest patents include the development of substituted bisphenyl butanoic ester derivatives as NEP inhibitors. The present disclosure provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R and R are defined herein. The disclosure also relates to a method for manufacturing the compounds and their therapeutic uses. Furthermore, it provides pharmaceutical compositions of the compounds and combinations of pharmacologically active agents with the compounds.
Career Highlights
Mark Kagan is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development and therapeutic applications.
Collaborations
Kagan has collaborated with notable colleagues such as Yongshuai Chai and Sven Erik Godtfredsen, contributing to advancements in their shared field of expertise.
Conclusion
Mark Kagan's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to pave the way for advancements in therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.